Idorsia announces positive results in the first Phase 3 study of daridorexant with improved overall sleep and daytime performance of patients with insomnia! We are very pleased to share with you the top line results of our Idorsia sleep study! The positive outcome of this study would not have been possible without our team and participants commitment and hard work ensuring safety and data integrity.
To learn more about the outcomes of the study click here: https://www.idorsia.com/media/news-details?newsId=2284972
